Investigating Pregnancy and Transplant Match Issues
Warren Fingrut, MD, discussed a study looking at HLA antibody burden among patients with blood cancers, particularly women who have carried multiple pregnancies.
Warren Fingrut, MD, discussed a study looking at HLA antibody burden among patients with blood cancers, particularly women who have carried multiple pregnancies.
When the liver is partially removed, the remaining portion can compensate and regain full function. Surgical oncologist Ching-Wei Tzeng, M.D., explains how the liver’s ability…
DCIS may often be overtreated in older women with limited life expectancy, according to research presented during the 2024 Society of Surgical Oncology Annual Meeting.
The FDA has withdrawn the approval of infigratinib for previously treated, FGFR2-positive, advanced cholangiocarcinoma.
As reported in the Journal of Clinical Oncology by Joel Neal, MD, PhD, and colleagues, the phase III CONTACT-01 trial has shown no significant improvement…
In an Indian single-center phase III trial (D-TORCH) reported in the Journal of Clinical Oncology, Santhosh et al found that the nonsteroidal, anti-inflammatory topical diclofenac…
An abstract is unavailable.
Artificial intelligence use in prostate cancer encompasses 4 main areas including diagnostic imaging, prediction of outcomes, histopathology, and treatment planning.
On April 30, 2024, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening for breast cancer. The USPSTF now recommends…
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number…
Adding abemaciclib to first-line nonsteroidal aromatase inhibitor treatment does not provide a significant improvement in OS for patients with HR+/HER2- advanced breast cancer, updated data…